Insmed Inc. buy Raymond James
Start price
10.04.26
/
50%
€133.40
Target price
10.04.27
€171.08
Performance (%)
-32.50%
Price
29.07.26
€91.15
Summary
This prediction is currently active. The BUY prediction by Raymond_James for Insmed Inc. is performing very badly with a performance of -32.50%. This prediction currently runs until 10.04.27. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1,01 % | 2,70 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % |
| iShares S&P 500 | -2,72 % | -1,75 % |
Comments by Raymond_James for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $200.00 price target on the stock.
Ratings data for INSM provided by MarketBeat